OSAM
WHWK

O'Shaughnessy Asset Management’s Whitehawk Therapeutics WHWK Stock Holding History

O'Shaughnessy Asset Management’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15
Closed – – 2567
2021
Q3 		$0 Hold
15
– – ﹤0.01% 2874
2021
Q2 		$0 Sell
15
-9
-38% -$206 ﹤0.01% 2709
2021
Q1 		$0 Buy
24
+9
+60% +$207 ﹤0.01% 2478
2020
Q4 		$0 Buy
+15
New +$321 ﹤0.01% 2249

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

O'Shaughnessy Asset Management's WHWK Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Whitehawk Therapeutics (WHWK) in Q4 2021, closing a stake of 15 shares.

O'Shaughnessy Asset Management first reported a position in WHWK in Q4 2020 and held it in 4 quarters. The position peaked at $0 in Q3 2021. 46 funds tracked by Wall St. Rank hold WHWK as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Whitehawk Therapeutics position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 15 Whitehawk Therapeutics shares in Q4 2021.
  • O'Shaughnessy Asset Management first reported a position in Whitehawk Therapeutics in Q4 2020 and held it in 4 quarters.
  • O'Shaughnessy Asset Management's Whitehawk Therapeutics position peaked at $0 in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.